Changing the beat
Coronary conditions are complex. Unchecked, they can cause devastating hardships for patients and health systems.
GE HealthCare is partnering with clinicians around the world to address your biggest challenges in cardiac care.
355%
24%
11M
8%
Post Processing
Revolution Apex
Revolution Vibe
Revolution Ascend
Revolution Maxima
AW Applications
CardiQ Suite
Revolution Apex
A cutting-edge scanner that delivers high-quality, reliable and repeatable image services for the most challenging patients that also meets future scalability needs.
Revolution Vibe
Scanner with advanced cardiac capabilities that delivers high-quality, reliable, and repeatable cardiac images, while also covering routine exams.
Revolution Ascend
Built for operational efficiency with an AI-based workflow and simple user interface this versatile scanner delivers high-quality reliable and repeatable images.
AW Applications
Discover how the AW Family application portfolio spans modalities and anatomies to help you handle simple to highly complex cases.
CardiQ Suite
An integrated suite of CT Cardiac post-processing tools, built for automation and workflow efficiency.
Cutting edge
An ecosystem that elevates patient care and operations
Our Cardiac CT solutions are bolstered by innovations that bring you to the leading edge of care.
Imaging Protocol Manager
Imaging 360
Centricity™ Cardio Enterprise
Disclaimers
*Separate application licenses must be purchased to access applications.
**Technology in development represents ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Not cleared or approved by the U.S. FDA or any other global regulator for commercial availability. This is neither an offer nor an agreement to supply the technologies. It cannot be placed on the market or put into service until it has been made to comply with the Medical Device Regulation requirements for CE marking.
**Technology in development represents ongoing research and development efforts. These technologies are not products and may never become products. Not for sale. Not cleared or approved by the U.S. FDA or any other global regulator for commercial availability. This is neither an offer nor an agreement to supply the technologies. It cannot be placed on the market or put into service until it has been made to comply with the Medical Device Regulation requirements for CE marking.
References
- “Cardiac Imaging Trends from 2010 to 2019 in the Medicare Population.” Collaborating with Dr. Reeves were Ethan J. Halpern, M.D., and Vijay M. Rao, M.D., FACR. Radiology: Cardiothoracic Imaging is edited by Suhny Abbara, M.D., University of Texas Southwestern Medical Center, Dallas, and owned and published by the Radiological Society of North America, Inc. (https://pubs.rsna.org/cardiothoracic-imaging)
- Grand View Research. Structural Heart Imaging Market Analysis & Segment Forecast From 2025 To 2030.
- https://www.frontlinehealthworkers.org/world-health-worker-week-2025
- Structural Heart Imaging Market Size, Share & Trends Analysis Report By Modality (Echocardiogram, Angiogram), By Procedure (TAVR, SAVR, TAVR, LAAO), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030.
- Data on file.
- The clinicians are paid consultants for GE HealthCare and were compensated for participation in this testimonial. The statements by the clinician described here are based on their own opinions and on results that were achieved in their unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e., hospital size, case mix, staff expertise, etc., there can be no guarantee that others will achieve the same results.